Elevated concentrations of FGF23 are responsible for impaired bone mineralization and so for more frequent fractures even if it is not simple to discriminate disease burden effects from phosphaturia/hypophosphatemia effects, because of correlation between FGF-23 levels and disease burden (6, 22, 57, 58). The gene discussed is FGF23; the disease is hypophosphatemia.